Pott's disease following BCG therapy of melanoma.
The first reported case of a patient with BCG-induced Pott's disease following immunotherapy for melanoma is presented. No signs or symptoms of the disease were detected for 2 1/2 years after therapy. The diagnosis and treatment of this complication of melanoma therapy are discussed.
D001500:BCG Vaccine / Q000009:adverse effects* / Q000627:therapeutic use; D001706:Biopsy; D003937:Diagnosis, Differential; D006801:Humans; D008159:Lumbar Vertebrae; D008297:Male; D008545:Melanoma / Q000628:therapy*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000628:therapy*; D014399:Tuberculosis, Spinal / Q000175:diagnosis / Q000209:etiology*
D001500:BCG Vaccine